Beta carotene/vitamin A cancer trial stopped early due to efficacy, safety concerns.
This article was originally published in The Tan Sheet
Executive Summary
NCI-FUNDED BETA CAROTENE/VITAMIN A TRIAL ON LUNG CANCER HALTED PREMATURELY in response to interim data indicating a lack of efficacy and possible adverse events, the National Cancer Institute announced Jan. 18. The active intervention phase of the six-center Beta Carotene and Retinol Efficacy Trial (CARET) in 18,000 high-risk men and women was slated originally to close in September 1997.
You may also be interested in...
Vitamin E Combined With Radiation Increases Risk Of Second Cancer – Study
Vitamin E supplementation significantly increased the risk of second primary cancer in patients undergoing radiation treatment for head or neck cancer, according to a study recently published in the Journal of the National Cancer Institute
Vitamin E Combined With Radiation Increases Risk Of Second Cancer – Study
Vitamin E supplementation significantly increased the risk of second primary cancer in patients undergoing radiation treatment for head or neck cancer, according to a study recently published in the Journal of the National Cancer Institute
Vitamin E Combined With Radiation Increases Risk Of Second Cancer – Study
Vitamin E supplementation significantly increased the risk of second primary cancer in patients undergoing radiation treatment for head or neck cancer, according to a study recently published in the Journal of the National Cancer Institute